FOX RUN MANAGEMENT, L.L.C. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
FOX RUN MANAGEMENT, L.L.C. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$220,000
-6.0%
1,750
-69.2%
0.20%
+29.0%
Q2 2019$234,000
-34.5%
5,685
-37.7%
0.16%
+78.2%
Q1 2018$357,000
-68.3%
9,118
-69.8%
0.09%
-72.7%
Q3 2017$1,127,000
+159.1%
30,200
+111.2%
0.32%
+112.7%
Q2 2017$435,000
-13.0%
14,300
-24.3%
0.15%
-26.5%
Q1 2017$500,00018,9000.20%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders